Article
Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.
Gastroenterology - 1 Oct 2011
Huang Yuehua, Tong Shuping, Tai Andrew W, Hussain Munira, Lok Anna S F
Abstract excerpt
BACKGROUND & AIMS: Clinical studies have associated hepatitis B virus core promoter (CP) mutations with an increased risk of hepatocellular carcinoma. The CP region overlaps with the HBV X (HBx) gene, which has been implicated in hepatocarcinogenesis. The cyclin kinase inhibitor p21WAF1/CIP1 is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
